Our data showed that benzyl‐α‐GalNAc treatment decreased the molecular weight of TYRO3 and MERTK (Fig. S5), suggesting that O‐glycans are also present in TYRO3 and MERTK in colon cancer cells. Here, TYRO3 is linked to colonic neoplasm.